Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 7,582 | 7,126 | 4,254 | 3,861 | 3,419 |
| Operating Income | -7,582 | -7,126 | -4,254 | -3,861 | -3,419 |
| Other Income | -1 | 2 | 2 | -6 | 25 |
| Pre-tax Income | -7,583 | -7,124 | -4,252 | -3,867 | -3,393 |
| Net Income Continuous | -7,583 | -7,124 | -4,252 | -3,867 | -3,393 |
| Net Income | $-7,583 | $-7,124 | $-4,252 | $-3,867 | $-3,393 |
| EPS Basic Total Ops | -2.88 | -3.24 | -2.16 | -2.52 | -2.40 |
| EPS Basic Continuous Ops | -2.88 | -3.20 | -2.14 | -2.40 | -2.44 |
| EPS Diluted Total Ops | -2.88 | -3.24 | -2.16 | -2.52 | -2.40 |
| EPS Diluted Continuous Ops | -2.88 | -3.20 | -2.14 | -2.40 | -2.44 |
| EBITDA(a) | $-7,569 | $-7,114 | $-4,242 | $-3,853 | $-3,417 |